Paper36930687
Inhibition of hepatic natural killer cell function via the TIGIT receptor in schistosomiasis-induced liver fibrosis.
Gao Y and 6 others. PLoS Pathog, 2023. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of hepatic natural killer cell function via the TIGIT receptor in schistosomiasis-induced liver fibrosis. Papers, record 36930687. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36930687
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of hepatic natural killer cell function via the TIGIT receptor in schistosomiasis-induced liver fibrosis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptors, Immunologic | Major topic |
| Schistosoma japonicum | Major topic |
| Schistosomiasis | Major topic |
| Schistosomiasis japonica | Major topic |
| Animals | |
| Mice | |
| Killer Cells, Natural | |
| Liver | |
| Liver Cirrhosis |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29601672 | MRI-guided interventional natural killer cell delivery for liver tumor treatment. | Cancer Med | 2018 | https://conductscience.org/library/papers/29601672 | PubMed |
| 2 | 28623459 | Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions. | Cancer Immunol Immunother | 2017 | https://conductscience.org/library/papers/28623459 | PubMed |
| 3 | 32430274 | Schistosomiasis Control: Leave No Age Group Behind. | Trends Parasitol | 2020 | https://conductscience.org/library/papers/32430274 | PubMed |
| 4 | 30951375 | The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis. | FASEB J | 2019 | https://conductscience.org/library/papers/30951375 | PubMed |
| 5 | 19011627 | The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. | Nat Immunol | 2009 | https://conductscience.org/library/papers/19011627 | PubMed |
| 6 | 34200375 | NKG2D Natural Killer Cell Receptor-A Short Description and Potential Clinical Applications. | Cells | 2021 | https://conductscience.org/library/papers/34200375 | PubMed |
| 7 | 32774149 | Research Progress on NK Cell Receptors and Their Signaling Pathways. | Mediators Inflamm | 2020 | https://conductscience.org/library/papers/32774149 | PubMed |
| 8 | 29915296 | Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. | Nat Immunol | 2018 | https://conductscience.org/library/papers/29915296 | PubMed |
| 9 | 34884223 | Clinical Spectrum of Schistosomiasis: An Update. | J Clin Med | 2021 | https://conductscience.org/library/papers/34884223 | PubMed |
| 10 | 26094914 | NKp30 isoforms in patients with chronic hepatitis C virus infection. | Immunology | 2015 | https://conductscience.org/library/papers/26094914 | PubMed |
| 11 | 34367161 | TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer. | Front Immunol | 2021 | https://conductscience.org/library/papers/34367161 | PubMed |
| 12 | 31270246 | NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing. | J Exp Med | 2019 | https://conductscience.org/library/papers/31270246 | PubMed |
| 13 | 32453422 | NK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells. | J Exp Med | 2020 | https://conductscience.org/library/papers/32453422 | PubMed |
| 14 | 30555485 | Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8+ T Cells. | Front Immunol | 2018 | https://conductscience.org/library/papers/30555485 | PubMed |
| 15 | 30150991 | Natural Killer Cells: Development, Maturation, and Clinical Utilization. | Front Immunol | 2018 | https://conductscience.org/library/papers/30150991 | PubMed |
| 16 | 34254141 | Schistosomiasis: still a neglected disease. | J Travel Med | 2021 | https://conductscience.org/library/papers/34254141 | PubMed |
| 17 | 22235358 | Negative regulation of Schistosoma japonicum egg-induced liver fibrosis by natural killer cells. | PLoS Negl Trop Dis | 2012 | https://conductscience.org/library/papers/22235358 | PubMed |
| 18 | 34959487 | The Dynamics of Hepatic Fibrosis Related to Schistosomiasis and Its Risk Factors in a Cohort of China. | Pathogens | 2021 | https://conductscience.org/library/papers/34959487 | PubMed |
| 19 | 23022478 | Natural killer and natural killer T cells in liver fibrosis. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/23022478 | PubMed |
| 20 | 34572463 | Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development. | Biomedicines | 2021 | https://conductscience.org/library/papers/34572463 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42160352 | Parasite exosomes-derived circulating sja-miR-61 and sja-miR-7-5p as Novel biomarkers for the detection of Schistosoma japonicum infection using TaqMan real-time PCR. | PLoS Negl Trop Dis | 2026 | https://conductscience.org/library/papers/42160352 | PubMed |
| 42001075 | Integrated transcriptomic and metabolomic profiling reveals immune-metabolic crosstalk and predictive biomarkers of ligustrazine treatment response in idiopathic pulmonary fibrosis. | J Transl Med | 2026 | https://conductscience.org/library/papers/42001075 | PubMed |
| 41798947 | TIGIT impairs NK cell antifibrotic activity through the IFNγ-IFI30 axis in schistosomiasis-induced liver fibrosis. | Front Immunol | 2026 | https://conductscience.org/library/papers/41798947 | PubMed |
| 40526725 | TIGIT blockade improves anti-Mycobacterium tuberculosis immunity. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40526725 | PubMed |
| 40244063 | Single-Cell Sequencing Reveals the Heterogeneity of Hepatic Natural Killer Cells and Identifies the Cytotoxic Natural Killer Subset in Schistosomiasis Mice. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40244063 | PubMed |
| 38393131 | Inhibiting Liver Autophagy and Promoting Hepatocyte Apoptosis by Schistosoma japonicum Infection. | Trop Med Infect Dis | 2024 | https://conductscience.org/library/papers/38393131 | PubMed |
| 38319102 | Beyond schistosomiasis: unraveling co-infections and altered immunity. | Clin Microbiol Rev | 2024 | https://conductscience.org/library/papers/38319102 | PubMed |
| 37239062 | The Important Roles of Natural Killer Cells in Liver Fibrosis. | Biomedicines | 2023 | https://conductscience.org/library/papers/37239062 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36930687
GET https://conductscience.org/api/papers/v1/36930687/references?page=2